ORIX CORP's Net Worth

$1.6 Billion

Estimate Recalculated Jul 5, 2024 03:35PM EST

Who is ORIX CORP?

ORIX CORP has an estimated net worth of $1.6 Billion. This is based on reported shares across multiple companies, which include Lument Finance Trust, Inc., ORMAT TECHNOLOGIES, INC., HOULIHAN LOKEY, INC., and Sucampo Pharmaceuticals, Inc..

SEC CIK

ORIX CORP's CIK is 0001070304

Past Insider Trading and Trends

2018 was ORIX CORP's most active year for acquiring shares with 4 total transactions. ORIX CORP's most active month to acquire stocks was the month of April. 2018 was ORIX CORP's most active year for disposing of shares, totalling 26 transactions. ORIX CORP's most active month to dispose stocks was the month of July. 2015 saw ORIX CORP paying a total of $0.00 for 40,800,909 shares, this is the most they've acquired in one year. In 2022 ORIX CORP cashed out on 4,312,500 shares for a total of $378,421,875.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lument Finance Trust, Inc. (LFT) Snapshot price: $2.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ORMAT TECHNOLOGIES, INC. (ORA) Snapshot price: $65.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.77%
-562.50K
$87.75
-$49,359,375.00
6.68M
Nov 25
Form 4
-34.13%
-3.75M
$87.75
-$329,062,500.00
7.24M
Nov 21
Form 3
—
0
—
—
0
No matching records found

HOULIHAN LOKEY, INC. (HLI) Snapshot price: $124.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.38M
$45.61
-$154,067,615.35
0
Jul 30
Form 4
+204.39%
2.27M
—
—
3.38M
Jun 28
Form 4
-73.00%
-3.00M
$45.52
-$136,545,000.00
1.11M
May 28
Form 4
+574.03%
3.5M
—
—
4.11M
Feb 21
Form 4
-2.08%
-12.98K
$48.02
-$623,155.54
609.72K
Aug 27
Form 4
+131.02%
353.15K
$48.03
-$1,979,951.22
622.7K
Aug 21 - Aug 22
Form 4
-8.17%
-23.98K
$48.10
-$1,153,512.07
269.55K
Aug 16 - Aug 17
Form 4
-13.12%
-44.33K
$48.50
-$2,150,013.87
293.53K
Aug 14
Form 4
-24.56%
-110.00K
$48.00
-$5,280,171.60
337.86K
Aug 9 - Aug 10
Form 4
-10.03%
-49.95K
$48.30
-$2,412,704.43
447.86K
Aug 7 - Aug 8
Form 4
-7.86%
-42.47K
$48.12
-$2,043,720.72
497.81K
Aug 3 - Aug 6
Form 4
-50.20%
-544.71K
$48.58
-$26,462,852.58
540.29K
Aug 1 - Aug 2
Form 4
+1,176.47%
1M
—
—
1.08M
Jul 9
Form 4
-89.13%
-697.00K
$49.11
-$131,761,295.13
85K
Jun 4
Form 4/A
-21.80%
-218.00K
$48.85
-$10,649,652.34
782K
May 16 - May 18
Form 4
-21.80%
-218.00K
$48.85
-$10,649,653.00
782K
May 16 - May 18
Form 4
+128.19%
561.76K
—
—
1M
May 9
Form 4
—
0
—
—
0
Mar 15
Form 4
-22.19%
-125.00K
$41.63
-$5,203,125.00
438.24K
Nov 3
Form 4
-75.65%
-1.75M
$41.63
-$72,843,750.00
563.24K
Oct 30
Form 4
-22.89%
-686.76K
$36.26
-$24,901,243.40
2.31M
Sep 12 - Sep 14
Form 4
+100.00%
1.5M
—
—
3M
Jul 26
Form 4/A
∞
1.5M
—
—
1.5M
May 17
Form 4
∞
1.5M
—
—
1.5M
May 17
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
$19.58
-$187,875,758.62
0
Aug 18
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Sucampo Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found